Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 16Unknown 8Active not recruiting 7Withdrawn 4Terminated 4Recruiting 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 10Hematologic Neoplasms 7Leukemia 6Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms 3Immunoblastic Lymphadenopathy 3Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Pain, Intractable 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Multiple Myeloma 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1

Interventions

Specimen Handling 1CVnCoV COVID-19 vaccine 1COH04S1 COVID-19 vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × COVID-19 × Other hematologic neoplasm × Clear all
NCT05672355 2026-05-20

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 2 Suspended
80 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡